Back to Search
Start Over
Effects of lysine 2-hydroxyisobutyrylation on bacterial FabI activity and resistance to triclosan.
- Source :
-
Biochimie [Biochimie] 2021 Mar; Vol. 182, pp. 197-205. Date of Electronic Publication: 2021 Jan 21. - Publication Year :
- 2021
-
Abstract
- Lysine 2-hydroxyisobutyrylation (K <subscript>hib</subscript> ) is a novel protein posttranslational modification conserved in eukaryotes and prokaryotes. However, the biological significance of K <subscript>hib</subscript> remains largely unknown. Here, through screening the proteome-wide K <subscript>hib</subscript> modification sites in bacteria using a bioinformatic method, we identified a potential K <subscript>hib</subscript> site (K201 <subscript>hib</subscript> ) targeted by de-2-hyroxyisobutyrylase CobB at the substrate-binding site of FabI, an enoyl-acyl carry protein reductase (EnvM or FabI) in fatty acid biosynthesis pathway. First, we confirmed that the previously identified de-2-hyroxyisobutyrylase CobB can remove K <subscript>hib</subscript> of FabI in an in vitro experiment. To investigate the biological effects of the K <subscript>hib</subscript> on FabI's activity, amino acid substitutes were introduced to the modification sites of the protein of E. coli origin to mimic modified/unmodified status. We found that the mutant mimicking K201 <subscript>hib</subscript> reduced FabI activity with decreased Michaelis constant (K <subscript>m</subscript> ) and catalytic turnover number (k <subscript>cat</subscript> ), while the mutant mimicking the unmodified form and the recombinant wild-type protein treated with CobB exhibited increased activity. However, the dissociation constant (K <subscript>D</subscript> ) between FabI and NADH was not affected by the mutation mimicking the modification, suggesting that K201 <subscript>hib</subscript> didn't alter the binding between NADH and FabI. We also found that K201 <subscript>hib</subscript> tended to increase the resistance of E. coli to triclosan (TCL), a widely-used antibiotics targeting FabI. Taken together, this study identified the regulatory role of K <subscript>hib</subscript> on FabI activity and pointed to a novel mechanism related to antibiotic resistance.<br />Competing Interests: Declaration of competing interest Authors have no competing interests to declare.<br /> (Copyright © 2021 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.)
- Subjects :
- Fatty Acid Synthase, Type II genetics
Fatty Acid Synthase, Type II metabolism
Drug Resistance, Bacterial drug effects
Drug Resistance, Bacterial genetics
Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) genetics
Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) metabolism
Escherichia coli enzymology
Escherichia coli genetics
Escherichia coli Proteins genetics
Escherichia coli Proteins metabolism
Protein Processing, Post-Translational drug effects
Triclosan pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1638-6183
- Volume :
- 182
- Database :
- MEDLINE
- Journal :
- Biochimie
- Publication Type :
- Academic Journal
- Accession number :
- 33485933
- Full Text :
- https://doi.org/10.1016/j.biochi.2021.01.011